Ditchcarbon
  • Contact
  1. Organizations
  2. Ginkgo
Public Profile
Pharmaceutical Preparation Manufacturing
US
updated 2 months ago

Ginkgo Sustainability Profile

Company website

Ginkgo Bioworks, often referred to simply as Ginkgo, is a pioneering biotechnology company headquartered in the United States. Founded in 2008, Ginkgo has established itself as a leader in the field of synthetic biology, focusing on designing custom microbes for a variety of applications across industries such as agriculture, pharmaceuticals, and food production. With major operational regions spanning North America and beyond, Ginkgo's innovative platform enables the rapid development of biological products. Their core offerings include engineered organisms that can produce valuable compounds, setting them apart through their unique approach to bioengineering. Notable achievements include significant partnerships and collaborations that have propelled Ginkgo to a prominent market position, making it a key player in the evolving landscape of biotechnology.

DitchCarbon Score

How does Ginkgo's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

25

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

34

Industry Benchmark

Ginkgo's score of 25 is lower than 60% of the industry. This can give you a sense of how well the company is doing compared to its peers.

40%

Let us know if this data was useful to you

Ginkgo's reported carbon emissions

In 2022, Ginkgo Bioworks, headquartered in the US, reported total carbon emissions of approximately 3,310,074 kg CO2e. This figure includes about 1,060,819 kg CO2e from Scope 1 emissions and approximately 2,254,255 kg CO2e from Scope 2 emissions. Notably, Ginkgo has not disclosed any Scope 3 emissions data. Despite the significant emissions reported, Ginkgo has not established specific reduction targets or initiatives as part of their climate commitments. The company does not currently participate in the Science Based Targets initiative (SBTi) or other recognised climate pledges. As Ginkgo Bioworks continues to operate within the biotechnology sector, it is essential for the organisation to develop and communicate clear climate strategies to align with industry standards and expectations for sustainability.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

2022
Scope 1
1,060,819
Scope 2
2,254,255
Scope 3
-

How Carbon Intensive is Ginkgo's Industry?

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Ginkgo's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

How Carbon Intensive is Ginkgo's Location?

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Ginkgo is in US, which has a low grid carbon intensity relative to other regions.

Ginkgo's Climate Goals (2030 & 2050)

Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.

Ginkgo has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Compare Ginkgo's Emissions with Industry Peers

Sherlock Biosciences, Inc.

US
•
Research and development services (73)
Updated 2 months ago

Biomerieux

FR
•
Pharmaceutical Preparation Manufacturing
Updated 6 days ago

Cue Health Inc.

US
•
Medical, precision and optical instruments, watches and clocks (33)
Updated 15 days ago

Amyris

US
•
Research and development services (73)
Updated 8 days ago

Illumina

US
•
Research and development services (73)
Updated 7 days ago

Biogen

US
•
Pharmaceutical Preparation Manufacturing
Updated 15 days ago

Let us know if this data was useful to you

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251117.1
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
AWS Marketplace logo
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy